BDBM50144407 CHEMBL308209::Quinoxaline-2-carboxylic acid [(1S,2S,4R)-2-hydroxy-1-(4-hydroxy-benzyl)-6-methyl-4-methylcarbamoyl-heptyl]-amide
SMILES: CNC(=O)[C@H](CC(C)C)C[C@H](O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cnc2ccccc2n1
InChI Key: InChIKey=HFUFFFSLWGHGEP-OUOWLKGYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-C chemokine receptor type 1 (Homo sapiens (Human)) | BDBM50144407 (CHEMBL308209 | Quinoxaline-2-carboxylic acid [(1S,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 610 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development Curated by ChEMBL | Assay Description Inhibition of CCL3 binding to C-C chemokine receptor type 1 | Bioorg Med Chem Lett 14: 2169-73 (2004) Article DOI: 10.1016/j.bmcl.2004.02.021 BindingDB Entry DOI: 10.7270/Q2833RGN | |||||||||||
More data for this Ligand-Target Pair |